BAKTERIENTHERAPIE FÜR CLOSTRIDIUM-DIFFICILE-COLITIS

European patent · EP4032586 · In force

Register entry

Publication number
EP4032586
Application number
EP22160187
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 1, 2011
Published
Jul 27, 2022
Granted
Aug 20, 2025
Protection ends at the latest
Jan 31, 2031
Next annual fee due
Feb 28, 2027
IPC classes
A61P 1/00 (2006.01)
C12N 1/04 (2006.01)
A61P 31/04 (2006.01)
A61P 1/12 (2006.01)
C12N 1/20 (2006.01)
Priority
US 33728310 P 01.02.2010
US 35118410 P 03.06.2010
Divided from
EP19176151
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 28, 2026

    Change

    Published in Swissreg on 28.05.2026

  2. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  3. Aug 20, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 20.08.2025

Parties

Holder

Ferring Microbiome Inc.

2660 Patton Road, Roseville, MN 55113, US

Inventor

HLAVKA, Edwin J

Minneapolis, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.